The Gamaleya National Research Center of Epidemiology and Microbiology of the Ministry of Health of the Russian Federation and the Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announced that the Sputnik V vaccine demonstrated efficacy of 97.6%, based on the analysis of data on the infection rate of...Full Article
Foreign Experts Assess Benefits Of Russia’s Sputnik V Coronavirus Vaccine – Analysis
Eurasia Review0 shares 1 views
Related news coverage
With a strong structured plan and that includes President Vladimir Putin weekly meetings with regional governors and related..